84190
2-(2-氨基乙基)-1,3-二-叔丁氧羰基-胍
≥90% (HPLC), for peptide synthesis
别名:
1,3-二-叔丁氧羰基-2-(2-氨基乙基)胍
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C13H26N4O4
化学文摘社编号:
分子量:
302.37
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.22
MDL number:
产品名称
2-(2-氨基乙基)-1,3-二-叔丁氧羰基-胍, technical, ≥90% (HPLC)
grade
technical
Quality Level
assay
≥90% (HPLC)
form
lumps
mp
95-98 °C
application(s)
peptide synthesis
shipped in
dry ice
storage temp.
−20°C
SMILES string
CC(C)(C)OC(=O)N\C(NC(=O)OC(C)(C)C)=N\CCN
InChI
1S/C13H26N4O4/c1-12(2,3)20-10(18)16-9(15-8-7-14)17-11(19)21-13(4,5)6/h7-8,14H2,1-6H3,(H2,15,16,17,18,19)
InChI key
GKQKBELHRNEGCI-UHFFFAOYSA-N
Other Notes
胍基化试剂
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
K C Nicolaou et al.
Bioorganic & medicinal chemistry, 6(8), 1185-1208 (1998-10-24)
Recent studies demonstrated that peptide and antibody antagonists of integrin alpha v beta 3 block angiogenesis and tumor growth. In this article, the design, synthesis and biological evaluation of a series of nitroaryl ether-based, nonpeptide mimetics are described. The design
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 489913-250MG | 04061833280669 |
| 84190-1G-F | 04061826725191 |
| 84190-5G-F | 04061833565339 |